Authors:
MURDTER TE
SPERKER B
BOSSLET K
FRITZ P
KROEMER HK
Citation: Te. Murdter et al., SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OFA GLUCURONYL PRODRUG OF DOXORUBICIN, DOXORUBICIN AND ITS METABOLITES IN HUMAN LUNG-TISSUE, Journal of chromatography B. Biomedical sciences and applications, 709(2), 1998, pp. 289-295
Authors:
MURDTER TE
SPERKER B
BACKMAN JT
FRIEDEL G
MCCLELLAN M
FRITZ P
BOSSLER K
KROEMER HK
Citation: Te. Murdter et al., BETA-GLUCURONIDASE EXPRESSION, ACTIVITY, AND LOCALIZATION OF IN HUMANLUNG-CANCER - A BASE FOR DRUG TARGETING, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4518-4518
Authors:
SPERKER B
TOMKIEWICZ C
BAROUKI R
KROEMER HK
Citation: B. Sperker et al., THAPSIGARGIN AND A23187-MEDIATED DOWN-REGULATION OF BETA-GLUCURONIDASE IN HEPG2 CELLS - CONSEQUENCES FOR DRUG TARGETING USING GLUCURONIDE PRODRUGS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4519-4519
Authors:
SPERKER B
TOMKIEWICZ C
BAROUKI R
KROEMER HK
Citation: B. Sperker et al., DRUG TARGETING BY GLUCURONIDE PRODRUGS - REGULATION OF THE BIOACTIVATING ENZYME BETA-GLUCURONIDASE IN THE HEPATOMA-CELL LINE HEPG2, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 62-62
Citation: B. Sperker et al., THE ROLE OF BETA-GLUCURONIDASE IN DRUG DISPOSITION AND DRUG TARGETINGIN HUMANS, Clinical pharmacokinetics, 33(1), 1997, pp. 18-31
Authors:
MURDTER TE
SPERKER B
FRIEDEL G
LINDER A
KIVISTO KT
MCCLELLAN M
FRITZ P
BOSSLET K
KROEMER HK
Citation: Te. Murdter et al., BIOACTIVATION OF A GLUCURONYL-SPACER-DOXORUBICIN PRODRUG BY BETA-GLUCURONIDASE - A STUDY USING THE HUMAN LUNG PERFUSION MODEL, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 455-455
Authors:
SPERKER B
MURDTER TE
SCHICK M
ECKHARDT K
BOSSLET K
KROEMER HK
Citation: B. Sperker et al., INTERINDIVIDUAL VARIABILITY IN EXPRESSION AND ACTIVITY OF HUMAN BETA-GLUCURONIDASE IN LIVER AND KIDNEY - CONSEQUENCES FOR DRUG-METABOLISM, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 914-920
Authors:
SPERKER B
MURDTER TE
FRITZ P
LINDER A
FRIEDEL G
BOSSLET K
EICHELBAUM M
KROEMER HK
Citation: B. Sperker et al., BIOACTIVATION OF A DOXORUBICIN GLUCURONIDE PRODRUG IN HUMAN LUNG AND BRONCHIAL-CARCINOMA - ROLE OF ELEVATED BETA-GLUCURONIDASE ACTIVITY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 24-24
Authors:
MURDTER TE
SPERKER B
KIVISTO KT
MCCLELLAN M
FRITZ P
FRIEDEL G
LINDER A
BOSSLET K
TOOMES H
DIERKESMANN R
KROEMER HK
Citation: Te. Murdter et al., ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE, Cancer research, 57(12), 1997, pp. 2440-2445
Citation: B. Sperker et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC QUANTIFICATION OF 4-METHYLUMBELLIFERYL-BETA-D-GLUCURONIDE AS A PROBE FOR HUMAN BETA-GLUCURONIDASE ACTIVITY IN TISSUE-HOMOGENATES, Journal of chromatography B. Biomedical applications, 685(1), 1996, pp. 181-184
Citation: B. Sperker et al., THE EXPRESSION OF HUMAN PLASMA CHOLESTERYL-ESTER-TRANSFER PROTEIN IN HEPG2 CELLS IS INDUCED BY SODIUM-BUTYRATE - QUANTIFICATION OF LOW MESSENGER-RNA LEVELS BY POLYMERASE CHAIN-REACTION, European journal of biochemistry, 218(3), 1993, pp. 945-950